LogicBio: AstraZeneca Acquires LogicBio for $68M to Bolster Genomics Pipeline
Gains technology platforms for the delivery and insertion of genes to address genetic diseases, and a platform to improve viral vector manufacturing.
Read full article »
LogicBio is a Massachusetts-based biotechnology company that researches and develops genetic medicines for the treatment of rare pediatric diseases.
Read more